R
Redhill Biopharma Ltd D
D
RDHL
0.62510
USD
-0.04
(-6.32%)
مغلق
حجم التداول
3,256
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
3,801,183
المقالات
العنوان: Redhill Biopharma Ltd
القطاع: الرعاية الصحية
الصناعة: Drug Manufacturers - Specialty & Generic
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.